Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis
Myasthenia gravis (MG) is a complex autoimmune disease affecting the neuromuscular junction with limited drug options, but the field of MG treatment recently benefits from novel biological agents. We performed...